Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin effect on serum uric acid in healthy men
ChiCTR-IPR-17013484Phase 4Not yet recruiting
- Sponsor
- Weishan People's Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in hyperuricemia, sponsored by Weishan People's Hospital. Primary endpoints: Blood pressure, Electrocardiogram and 1 more. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on ChiCTR-IPR-17013484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013484.